Targeting the gut–lung microbiota axis by means of a high-fibre diet and probiotics may have anti-inflammatory effects in COVID-19 infection
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) 1 is a 2019 novel coronavirus, which only in the European area has led to more than 300,000 cases with at least 21,000 deaths. This manuscript aims to speculate that the manipulation of the microbial patterns through the use of probiotics...
| Published in: | Therapeutic Advances in Respiratory Disease |
|---|---|
| Main Authors: | , |
| Format: | Article |
| Language: | English |
| Published: |
SAGE Publishing
2020-06-01
|
| Online Access: | https://doi.org/10.1177/1753466620937170 |